PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-09-13 | Pages: 200+ | Report ID: WR-2024-09-13-169991 | Services
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Pharmaceuticals and Biotechnology R&D Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET
7.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 ROCHE
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 GLAXOSMITHKLINE
16.3 JOHNSON & JOHNSON
16.4 NOVARTIS
16.5 PFIZER
16.6 MERCK
16.7 BRISTOL-MYERS SQUIBB
16.8 SANOFI
16.9 ASTRAZENECA
16.10 BAYER
16.11 TAKEDA PHARMACEUTICAL
16.12 BIOGEN
16.13 NOVO NORDISK
16.14 ABBVIE
16.15 AMGEN
16.16 BOEHRINGER SOHN
16.17 ASTELLAS PHARMA
16.18 GILEAD SCIENCES
16.19 ELI LILLY
16.20 ABBOTT
16.21 TEVA PHARMACEUTICAL INDUSTRIES
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeDrug
Medical Equipment
Vaccine
Others
By Application
Hospital
Clinic
Homecare
Others
Companies
ROCHE
GLAXOSMITHKLINE
JOHNSON & JOHNSON
NOVARTIS
PFIZER
MERCK
BRISTOL-MYERS SQUIBB
SANOFI
ASTRAZENECA
BAYER
TAKEDA PHARMACEUTICAL
BIOGEN
NOVO NORDISK
ABBVIE
AMGEN
BOEHRINGER SOHN
ASTELLAS PHARMA
GILEAD SCIENCES
ELI LILLY
ABBOTT
TEVA PHARMACEUTICAL INDUSTRIES
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.